Click on the ticker for details on a company
Recent Activity in the Marketplace
- Orig3n Acquires Interleukin Genetics CLIA laboratory
November 22, 2017 — Orig3n, Inc., a Boston-based biotech company, announced the acquisition of Interleukin Genetics’ CLIA laboratory and their remaining assets. Interleukin Genetics’ technology will become a core component of Orig3n’s DNA test business. Orig3n collects DNA samples and researches and develops treatments for genetically inherited diseases. The company operates an online application for selling DNA test kits.
- Quotient Sciences Acquires Pharmaterials
November 14, 2017 — Quotient Sciences, a drug development services organization, acquired Pharmaterials Ltd., a contract development and manufacturing organization supporting the development of small molecule drug products for oral and inhaled delivery. The acquisition strengthens and expands Quotient’s footprint following the acquisitions of SeaView Research and QS Pharma in February 2017.
- Absorption Systems Acquires TGA Sciences
November 13, 2017 — Absorption Systems acquired TGA Sciences, Inc., a contract R&D laboratory. TGA Sciences, Inc. will become TGA Bioservices LLC, a subsidiary of Absorption Systems, a developer of GLP and GMP-compliant in vitro cell-based as well as in vivo animal models for clients in the pharmaceutical and gene/cell therapy space. The acquisition expands Absorption Systems’ expertise in research and GxP assay development services and provides Absorption Systems access to customers in the expanding Boston/Cambridge biotech hub.
- Almac Group Buys BioClin Laboratories
November 1, 2017 — Almac Group, a global contract development and manufacturing organization, has acquired BioClin Laboratories, an independent and privately owned organization based in Athlone, Ireland. BioClin provides analytical services including cGMP pharmaceutical and biopharmaceutical analysis, GMP microbiology testing and GLP bioanalysis. The company offers a GLP certified (INAB), cGMP certified (HPRA) and FDA registered contract laboratory.
- Citoxlab Acquires Xenometrics
October 31, 2017 — CiToxLAB, a non-clinical CROs, acquired Xenometrics, Inc., a CRO specialized in the non-clinical assessment of new drug candidates. This acquisition is the third one made by Citoxlab in North America following the acquisition of the LAB Research Group and Accellab. The financial terms of the agreement were not disclosed. Xenometrics offers a range of services in the fields of safety, pharmacology and pharmacokinetics to customers from the pharmaceutical, biotechnology and chemical industries.
- Quest Diagnostics Acquires California Laboratory Associates
October 30, 2017 — Quest Diagnostics, a provider of diagnostic information services, has acquired assets of California Laboratory Associates (CLA), a clinical lab network serving patients and providers in the Greater Los Angeles Area. Quest will add several CLA patient service centers to its network in the San Fernando Valley and neighboring communities.
- Concept Life Acquires Aquila BioMedical
October 30, 2017 — Concept Life Sciences, an integrated drug discovery, development and analytical services company, has acquired Aquila BioMedical, a pre-clinical contract research organization with expertise in immuno-oncology, immunology and multiplex histology. Aquila is based in Edinburgh, Scotland and offers services covering a wide range of in vitro and in vivo proof-of-concept studies.
- Archive of Activity in the Marketplace